ANI Pharmaceuticals Competitors and Similar CompaniesClear all

ANI Pharmaceuticals's competitors and similar companies include Sorrento Therapeutics and Merus.
ANI Pharmaceuticals
ANI Pharmaceuticals
ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A.
Sorrento Therapeutics
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Merus
Merus
Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
Founding Date
Founding Date
1996
Founding Date
2006
Founding Date
2003
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Baudette, US HQ
Oakville, CA
Baudette, US
Locations
San Diego, US HQ
San Diego, US
Locations
Utrecht, NL HQ
Cambridge, US
Employees
Employees
33813% increase
Employees
31019% decrease
Employees
260
Valuation ($)
Valuation ($)
1.2 b
Valuation ($)
1.5 m
Valuation ($)
3.6 b

Financial

Revenue (est.)
Revenue (est.)
$883.4m (FY, 2025)
Revenue (est.)
$62.8m (FY, 2022)
Revenue (est.)
$36.1m (FY, 2024)
Net income
Net income
N/A
Net income
($577.8m) (FY, 2022)
Net income
($215.3m) (FY, 2024)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 42.6m
Total funding raised
$ 149.3m
For sources of this data, please see the company profile

View Company Profiles

Sorrento Therapeutics
HQ
San Diego, US
Employees
310↓ 19% decrease

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.

View company
Merus
HQ
Utrecht, NL
Employees
260

Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.

View company